During the past decade, Bozeman Deaconess Hospital conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 153 clinical trials were completed, i.e. on average, 71.2% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 91 clinical trials were completed. i.e. 104.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bozeman Deaconess Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 176 trials, followed by "SWOG Cancer Research Network" with 66 trials sponsored, "Alliance for Clinical Trials in Oncology" with 53 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bozeman Deaconess Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 177 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Bozeman Deaconess Hospital" are "Breast Cancer" (17 trials), "Recurrent Breast Carcinoma" (12 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Bozeman Deaconess Hospital" in a lesser frequency.

Most popular intervention types in "Bozeman Deaconess Hospital" are "Drug" (305 trials), "Other" (213 trials), "Biological" (147 trials), "Procedure" (88 trials) and "Radiation" (55 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (106 trials), "Quality-of-Life Assessment" (83 trials), "Questionnaire Administration" (47 trials), "Paclitaxel" (41 trials) and "Carboplatin" (38 trials). Other intervention names were less common.

The vast majority of trials in "Bozeman Deaconess Hospital" are 293 trials for "All" genders, 62 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Bozeman Deaconess Hospital". undefined are not yet recruiting, 79 are recruiting, 149 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 110 completed trials in Bozeman Deaconess Hospital, 8 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Bozeman Deaconess Hospital, 16 "Phase 1" clinical trials were conducted, 186 "Phase 2" clinical trials and 178 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".

Bozeman Deaconess Hospital has several departments that took part in Clinical trials: "Bozeman Deaconess Cancer Center" - 162 trials, "Internal Medicine Associates of Bozeman" - 20 trials, "Bozeman Health GI Clinic" - 2 trials